Stock data

台生材 (6649)

台生材 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$17.02M, down 49.3% from a year earlier. EPS over the last four quarters totals NT$0.79.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 台生材 in Insightr